Article Details
Retrieved on: 2021-02-24 07:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer and BioNTech will supply half of the total doses, with the remainder sourced from Britain's AstraZeneca, Russia's Gamaleya Research Institute, ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here